100% of over 80s in Spain have received at least 1st Covid jab

100% of over 80s in Spain have received at least 1st Covid jab.

SPAIN’S roll-out of the Covid vaccine has gathered momentum in recent weeks and all autonomous communities have stepped up regional campaigns, setting up facilities to vaccinate seven days a week in some cases.

So much so that 100 per cent of all those over the age of 80 have now received at least their first jab and more than three quarters (78 per cent) have completed the vaccine programme.

Two thirds (67 per cent) of those aged between 70 and 79 have also received both doses.

In the last week, more than 400,000 daily injections have been administered, and the vaccination of people aged 60 to 69, who have been given the AstraZeneca drug, has accelerated with almost half of this age group having received their first dose.

“Everything that arrives is administered. There is no community that goes below 89 per cent of injected doses of the total received”, stressed Julián Domínguez, epidemiologist of the Spanish Society of Preventive Medicine, Public Health and Hygiene.

According to the Ministry of Health on Monday, April 26, prior to the receipt that day of the last shipment of vaccines from Pfizer, the vast majority of the communities had already administered around 90 per of the doses received.

Since the start of the vaccination campaign, more than 11 million people – almost a quarter of the population (23.2 per cent) – have received at least one dose and four million (8.5 per cent) have completed the vaccination program.

Six hundred volunteers are being sought by the Carlos III Health Institute to take part in a trial that will determine if Pfizer can be given as a second dose to those who have received a first jab of AstraZeneca’s vaccine.

The government-backed CombivacS trial specifically needs people under the age of 60 who received an AstraZeneca jab before March 5 to take part.

“The trial began on Monday (April 26) with the aim of studying the possible benefits of a combination of vaccines to complete immunization against Covid-19, and the possibility of receiving volunteers to participate in the study,” reads a statement.